Cannabis
Fiore Cannabis Directs Focus on Core U.S. Assets and Turnaround Position
Kelowna, British Columbia–(Newsfile Corp. – March 4, 2021) – Fiore Cannabis Ltd. (CSE:FIOR) (OTCQX:FIORF) (“Fiore” or the “Company”), a licensed multi-state cannabis cultivator, producer and retailer, today announced it has entered into the following investor relations and/or marketing arrangements:
- North Equities – Consulting and social media services – 512,820 common shares issued at a deemed price of $0.195 per share as payment of $75,000 invoice to the Company for a six-month period;
- CFN Media Group – Corporate communications, marketing and investor relations services – 163,092 common shares issued at a deemed price of $0.21 per share as payment of $34,000 invoice to the Company for a three-month period;
- Hybrid Financial – Investor relations and marketing activities – Total cash consideration of $75,000 for a six-month period; and
- Market One Media Group – Corporate communications, marketing and investor relations services – Total cash consideration of $150,000 represents ongoing arrangement established and paid for in 2020.
In each case, the Company and counterparty maintain an arm’s-length relationship, and none of the noted entities has any interest, directly or indirectly, in the securities of the Company other than as set forth above.
“We are being disciplined and committed to our core abilities as a company. Fiore cultivates premium organic cannabis products in its Nevada operations and sells cannabis directly to customers from its California retail operations. We expect to focus on these specific U.S. markets and look to vertically integrate activities in those states. When we changed our company name last fall to Fiore Cannabis, we did so knowing it would be a part of our turnaround story and we continue on that path. We’re generating recognition for our top-quality products, partnering strategically with companies that will amplify our capabilities, and delivering significant value to our shareholders,” said Erik Anderson, President and CEO of Fiore Cannabis.
About Fiore Cannabis
Fiore Cannabis Ltd. (CSE:FIOR) (OTCQX:FIORF) is a publicly traded company that has been investing in the development of medical and recreational cannabis products since 2014. Fiore has expanded its operating portfolio to include cultivation, production and retail offerings in our key North American legal jurisdictions of Nevada and California. For more information, please visit www.fiorecannabis.com.
For Further Information:
Erik Anderson, President and CEO
1-877-438-5448 Ext. 713
[email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/76079
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis6 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis6 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
SCHWAZZE4 days ago
Schwazze Announces First Quarter 2024 Financial Results
-
Cannabis4 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
Cannabis5 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth